刘雪琴,褚俊峰,王海英.PET-CT定量参数与弥漫大B细胞淋巴瘤患者预后的相关性分析[J].肿瘤学杂志,2020,26(10):897-901. |
PET-CT定量参数与弥漫大B细胞淋巴瘤患者预后的相关性分析 |
Correlation of Quantitative PET-CT Parameters with Prognosis of Patients with Diffuse Large B-cell Lymphoma |
投稿时间:2019-10-09 |
DOI:10.11735/j.issn.1671-170X.2020.10.B009 |
|
|
中文关键词: 弥漫大B细胞淋巴瘤 最大标准化摄取值 氟脱氧葡萄糖F18 预后 |
英文关键词:diffuse large B cell lymphoma maximum standard uptake value fluorodeoxyglucose F18 prognosis |
基金项目:国家自然科学基金(81470365) |
|
摘要点击次数: 1048 |
全文下载次数: 238 |
中文摘要: |
摘 要:[目的] 探讨弥漫大B细胞淋巴瘤(DLBCL)治疗前18F-FDG PET/CT显像中肿瘤SUVmax、SULmax、MTV、TLG与预后的相关性。[方法]回顾性分析诊治的116例DLBCL患者资料,所有患者治疗前行18F-FDG PET/CT显像,均有完整的临床随访数据。分析PET-CT代谢参数与预后的关系。[结果] SUVmax、SULmax与DLBCL患者年龄、分期、Hans分型、结外病变个数及Ki-67间无相关性(P均>0.05)。取SUVmax、SULmax、MTV、TLG中位数(分别为18.64、17.65、22.74、221.84)为界值,单因素分析显示Ann Arbor 分期、结外病变个数、Hans分型、 SULmax是患者 PFS 的影响因素(P均<0.05);多因素分析显示Ann Arbor 分期、结外病变个数、Hans分型是患者 PFS 的独立影响因素(P均<0.05)。[结论] 治疗前PET-CT定量参数对DLBCL患者预后预测意义不明确,目前还不能通过其来判断预后或指导治疗。 |
英文摘要: |
Abstract:[Objective] To explore the correlation of quantitative PET-CT parameters with prognosis of patients with diffuse large B-cell lymphoma (DLBCL). [Methods] The clinical and imaging data of 116 patients with DLBCL were retrospectively analyzed. All patients underwent 18F-FDG PET/CT examination before treatment and had complete clinical follow-up data. The relationship between metabolic parameters of PET-CT and prognostic factors,short-term efficacy and long-term survival was evaluated. [Results] SUVmax,SULmax had no correlation with age,stage,Hans type,number of extranodal lesions,and Ki-67(all P>0.05). Taking the median values of SUVmax,SULmax,MTV,and TLG (18.64, 17.65,22.74,221.84,respectively) as the cut-off values,univariate analysis found that Ann Arbor stage,number of extranodal lesions,Hans type,and SULmax were associated with PFS of patients (all P<0.05);multivariate analysis results showed that Ann Arbor staging,number of extranodal lesions,and Hans type were independent factors of PFS(all P<0.05). [Conclusion] The study shows that the significance of PET-CT quantitative parameters before treatment in prognosis of DLBCL patients is not clear,and it may not be used to judge prognosis or guide treatment for DLBCL patients. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |